Barclays initiates Humacyte coverage at Equal Weight, $0.5 target
Barclays started coverage of Humacyte (HUMA) with an Equal Weight rating and a $0.5 price target.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.